Christopher Sobecki

Christopher J. Sobecki is a Managing Director of The Invus Group, LLC, which he joined in 1989. He is focused on investments in private companies and today is based in the firm's Jackson, Wyoming office. Before joining Invus, he worked as an engineer for the Eastman Kodak Company. He holds a B.S. in industrial engineering from Purdue University and an M.B.A. from Harvard Business School.

Invus is a global investment firm founded in 1985 (led by Raymond Debbane) that provides equity capital to owner-managers looking to transform their industries. A distinctive feature of the firm is that it does not raise money in the traditional closed-end fund structure — meaning there is no fixed "investment clock" or pressure to exit positions to raise a successor fund, allowing it to hold investments over very long horizons.

Sobecki's most prominent involvement was the Weight Watchers transaction. When H.J. Heinz put its Weight Watchers unit up for sale in 1999, the Artal Group (managed by Invus) acquired it in a leveraged buyout valued at roughly $735 million, putting down about $224 million in equity and financing the rest with debt — a deal that generated multiples of billions in returns over the following two decades and is often cited as one of the great private-equity outcomes. Sobecki became a director of Weight Watchers (later WW International, Inc.) upon Artal's acquisition on September 29, 1999, and served on the board until stepping down effective May 31, 2023, after roughly 24 years.

Alongside his private-company work, Sobecki has held public-company board seats. He has been a director of Lexicon Pharmaceuticals, Inc. since August 2007 and serves as a member (and reportedly Chairman) of that board. He also sits on the board of directors of Thrive Market as one of the Invus Group Managing Directors, and he is a director of a number of other private companies in which Invus or Artal Group S.A. have invested. He has additionally been associated with Tufts University's global leadership programs.

• Invests through The Invus Group, which "specializes in providing equity capital to owner-managers with the vision to transform their industries" — the emphasis is on backing strong operators, not passive minority bets.
• Sectors: consumer, healthcare, and technology — the areas where Invus has built companies since 1985.
• Long-hold, patient capital: Invus does not operate a conventional fund with a fixed life, so it can hold positions for many years (Weight Watchers/WW held 1999–2020s; Lexicon board seat since 2007) — attractive for founders who don't want a forced near-term exit.
• Concentrated, transformational stakes rather than a spray of small seed checks — Sobecki's track record is anchored in large control/growth positions where Invus takes an active board and strategy role.
• Sobecki personally contributes "expertise in risk assessment and business strategy development," and is active in the "identification, selection, negotiation and oversight of investments," per Lexicon's proxy disclosures.